The global interbody spine implants market is expected to generate $2,471.8 million revenue in 2030, advancing at a CAGR of 2.9% during 2021–2030. This can be ascribed to the rapid adoption of minimally invasive spine surgeries, rise in the elderly population, sedentary lifestyle, and advancements in augmented and virtual reality. Furthermore, the increase in incidences of spinal disorders and surge in product innovations fuel the market growth.
The lumbar category dominates the market and it is expected to grow with more than 3% CAGR during 2021–2030. This is due to the rapid rise in spinal procedures, as a result of a large number of people suffering from low back pain. Lumbar degenerative disease is a common disabling condition that causes people pain and disability, resulting in an increase in the number of surgeries. Furthermore, modern technologies and implants are required to perform such surgeries, which, in turn, the market for lumbar products is growing.
The demand for metal-based implants contributed the largest revenue share to the market in 2021, and the category is expected to retain its position during the forecast period as well. These implants are the most common in use due to their durability, flexibility, and robustness, and are made up of metals such as titanium, stainless steel, and tantalum. These implants are used to correct spinal deformities, stabilize, and strengthen the spine, and promote fusion.
The hospitals category holds the largest revenue share among all end users in the market. This is because hospitals perform a large number of spine procedures to treat various spine disorders, due to their enhanced healthcare facilities and the presence of skilled spine surgeons.
Geographically, North America is the major revenue contributor to the interbody spine implants market, and it is projected to witness the same trend in the coming years as well. This is ascribed to the rise in acceptance of advanced devices and implants in spinal surgeries, surge in the number of procedures due to the rapidly growing geriatric population, and increase in incidences of spinal disorders. However, the APAC market is expected to grow at the highest CAGR during the forecast period. The increase in expenditure in emerging markets, such as India and China, and the improvement in healthcare infrastructure to address major medical requirements boost the demand for spinal implants and devices in the region.
Product launches and acquisitions are the major steps taken by players to compete in the market. For instance, in February 2021, DeGen Medical Inc. launched a 3D-printed porous titanium implant for posterior interbody fusion named, Impulse AM. It represents the first interbody device in the DeGen Medical 3D-printed Puri-Ti portfolio.
In February 2021, NuVasive Inc. acquired Simplify Medical Inc., a developer of Simplify Disc for cervical total disc replacement (cTDR). The acquisition helps the company add the most clinically effective cTDR technology and further distinguish its cervical portfolio in the industry.
Major players operating in the interbody spine implants market include Medtronic Plc, NuVasive Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., and Johnson & Johnson.